Log in

View Full Version : Articles of Interest


Pages : 1 2 3 4 5 6 7 8 9 10 11 12 13 14 [15] 16 17 18

  1. The rationale for prophylactic cancer vaccines and need for a paradigm shift (1 replies)
  2. Hey R.b...!!!! (1 replies)
  3. New Drug Can Create Bone (5 replies)
  4. Nimotuzumab...Another anti Her2 drug in the pipeline (0 replies)
  5. Receptor Biologix...This company is focusing on a treatment that will shut down... (0 replies)
  6. Fish oil (2 replies)
  7. New computed radiotherapy(electron+X-Ray) effective & very reduced collateral damage (0 replies)
  8. New early molecular method of cancer detection (0 replies)
  9. Track record (0 replies)
  10. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in... (0 replies)
  11. carboplatin with herceptin and paxel in met. bc improved... (0 replies)
  12. preclinical study of combiining Windber her2neu peptide vaccine with Herceptin (0 replies)
  13. More Americans too fat for xrays and scans (0 replies)
  14. if considering statins to decrease recurrence risk--risk uncovrng neuromusclr disease (0 replies)
  15. preclinical: metronomic chemotherapy (oral) produced remarkable prolongn of survival (20 replies)
  16. Listen up bitches and queens (sorry!) cox2 associated with breast cancer in dogs,cats (3 replies)
  17. Kosan Presents Clinical Results Showing Anti-tumor (0 replies)
  18. Studies on mice may reveal why some are more suspectible to carcinogens... (1 replies)
  19. Herceptin added to hormonal therapy prolongs progression-free survival for patients w (0 replies)
  20. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2 (0 replies)
  21. 1st ASCO guidelines on impact of chemo and fertility... (2 replies)
  22. more on CEF as best chemo for her2+... (0 replies)
  23. not only does the tumor's Ki67 but so does its ER and PR status (with menstrual phase (5 replies)
  24. Oestrogens and progesterone in cows milk but how much and what impact? (5 replies)
  25. e tag (0 replies)
  26. BBC:Enzyme (protein) link between cystic fibrosis, obesity, cancer and diabetes found (1 replies)
  27. 'Help Defeat Cancer' Project to Speed Cancer Research (2 replies)
  28. Breast Cancer Update 2006 #4: unusual case reports & clinical trial comments (0 replies)
  29. Involvement ERBS at fundamantal level in human development (0 replies)
  30. Celecoxib (low doasage) plus DHA inhibits P53 (0 replies)
  31. Brain cancer research at M.D. Anderson:very informative article (may 2006) (1 replies)
  32. a new kind of her2neu +er= breast cancer type--baso-luminal! (2 replies)
  33. presence of circulating tumor cells bad prognositic sign at any stage of mbctreatment (3 replies)
  34. for those running out of options: metronomic abraxane (0 replies)
  35. CNS mets of those on herceptin is a hot topic with the neurooncologists! (0 replies)
  36. CNS mets of those on herceptin is a hot topic with the neurooncologists! (0 replies)
  37. more on Velcade (0 replies)
  38. CISH- Chromogenic In Sity Hybridization (New HER2 test) (0 replies)
  39. researchers moving in on earlier detection of bone metastases in breast cancer (10 replies)
  40. Preliminary indications that brain metastases are distinct from primary breast tumors (1 replies)
  41. ALA in diet necessary for betacarotene protective effect against breast cancer (1 replies)
  42. breast feeding on one side Significantly increases bc.... (0 replies)
  43. Assymetry of breasts linked to increased bc.... (0 replies)
  44. Recent article linking high breast density/ breast cancer to heredity (0 replies)
  45. a subgroup of breast cancer patients in whom radiation therapy makes a big difference (0 replies)
  46. Pesticide residues in fat associated with adjacent breast tumors (1 replies)
  47. more on cardiotoxicity of anti her2 monoclonal antibodies like herceptin (1 replies)
  48. A highly predictive marker of chemo resistance/ efficacy (0 replies)
  49. Boosting Killer Cells Might Improve Breast-Cancer Drug (0 replies)
  50. research on which breast cancer patients get CNS mets (1 replies)
  51. Amazing article on omega3 and BC prevention... (6 replies)
  52. Dietary supplements of no benefit to patients with cancer or precancerous lesions (0 replies)
  53. More on the benefits of physical exercize for BC patients (0 replies)
  54. IL-21 makes herceptin much more effective by boosting Natural KillerCells (4 replies)
  55. Resistance to Herceptin: any comments? (1 replies)
  56. txr1 gene found to cause resistance to taxane drugs & thrombospondin overcomes it (0 replies)
  57. An other interleukin (-21) as potential booster for Herceptin (0 replies)
  58. 100% inhibition of neovascularization of breast cancer in mice with DNA encoding AMA (0 replies)
  59. immunotherapy: converting her2+ breast cancer cells into antigen presenting cells (0 replies)
  60. new serum marker of bone mets (0 replies)
  61. The Ugly Side of Pretty (1 replies)
  62. Flouride additatives oral products - impact on immume system? stimulates superoxides? (6 replies)
  63. more on velcade (bortezomid) vs herceptin resistant her2+ breast cancer (0 replies)
  64. Testosterone, anyone? (0 replies)
  65. urine test for early detection of bone mets being developed (0 replies)
  66. Olive leaves show cancer killing potential (0 replies)
  67. Metabolic syndrome predicts breast cancer relapse (0 replies)
  68. New proposed standards for IHC/FISH tests.Low volume labs not as good as high volume (0 replies)
  69. Even low dose radiotherapy may cause bone loss if mice study is confirmed (0 replies)
  70. Brain cancer:first case report of response to chemo added to extended Herceptin (0 replies)
  71. Is anemia hindering cancer treatment? It may at least for colorectal cancer (0 replies)
  72. A new class of hybrid targeted therapy drugs in animal testing (0 replies)
  73. risk of CNS (brain) mets in breast cancer examined as related to type of breastcancer (0 replies)
  74. Significant Advance in Treatment of Breast Cancer Reported:small study of chemo+tipif (2 replies)
  75. Genetic Flaw Doubles Breast Cancer Risk (1 replies)
  76. Cancer & anemia: treatment options for anemia (2 replies)
  77. Antiangiogenesis update:lecture by Dr M.J. Folkman(28 april 2006) (0 replies)
  78. Post ASCO: recorded webcast by Dr K. Pritchard (6 jul 2006) (0 replies)
  79. What makes a good patient? ... (2 replies)
  80. Superfoods...note Hemp seeds rich in Omega 6 AND 3 (0 replies)
  81. inspiring Wall Street Journal article on woman fighting her disease (0 replies)
  82. Tykerb? (0 replies)
  83. Weight gain & fatigue:chemo induced hypothyroidism? (0 replies)
  84. Post menopause - oestrogen and body fat (0 replies)
  85. Post menopause - oestrogen and body fat (1 replies)
  86. In breast cancer in general (not specifically her2 br HRT assoctd w imprvd survival (0 replies)
  87. protein discovered that helps tumor evade body defenses and stimulates angiogenesis (0 replies)
  88. Alpha lipoic acid reduces VEGF ?? (0 replies)
  89. Cutting off Cancer's Energy Supply (3 replies)
  90. omega 6/3 ratio linked to suicide risk! (1 replies)
  91. A small study of chemo brain with unexpected results (1 replies)
  92. New guidelines for PET scan use in trials & in monitoring treatments (0 replies)
  93. gene induction by {omega}-6...COX-2, IL-1ß, CXCL-1, TNF, IL-6, LTA, IL-8 + PGE2 PI3K. (0 replies)
  94. GLA Inhibits Her2 (1 replies)
  95. Radioactice scorpion venom (!) for brain cancer (1 replies)
  96. Cyberknife for radiation resistant metastatic lungs from breast (0 replies)
  97. Body fat content, body weight, Leptin, increased aromatase expression (0 replies)
  98. Link to trials involving CoQ10 (1 replies)
  99. any of you actively in the Seattle vaccine trial (2 replies)
  100. NSAID inhibits ER and PR expression and inhibits ER and PR signalling ! (0 replies)
  101. Natural endogenous antiangiogenic molecule deficient in breast cancer (0 replies)
  102. for those running out of options--new Genentech taxane starting Phase I (0 replies)
  103. It may turn out that its best to combine VEGF inhibitors with radiation tx or chemo (1 replies)
  104. omega 3 fatty acid effects on biochemical indices following cancer surgery--RBnotice (2 replies)
  105. Joe, Al stumbled across this issue with LOTs of relevant articles (2 replies)
  106. Suggestions that enhanced levels of omega three may moderate post surgical inflamatio (0 replies)
  107. Explains the medication phentermine (1 replies)
  108. OFF topic, but interesting article on obesity... (0 replies)
  109. Breast Cancer Update 2006 (#3):lots of info (0 replies)
  110. Complete excision of primary tumour to improve survival of metastatic cancer patients (0 replies)
  111. Chest X-rays may increase risk to BRCA1/2 carriers (0 replies)
  112. Making your pet scan more accurate (2 replies)
  113. Flavanoids benifts of - inhibition of FAS possible main pathway (0 replies)
  114. Medical Chronotherapy for cancer? (5 replies)
  115. lack herceptin response lowered with PI3K inhibitor... (5 replies)
  116. Early stage BC chemo prevention of recurrence "are only one in 20 to one in 100" ? !! (1 replies)
  117. natural cox2 inhibitor (8 replies)
  118. Latest MD Anderson Studies (0 replies)
  119. Omega thrre six and MCF-7 Human Breast Cancer Xenografts (1 replies)
  120. CTLA4 monocloncal antibody combined with vaccine (0 replies)
  121. BRCA testing update (2 replies)
  122. A warm blanket(& no coffee) for a more accurate PET scan (1 replies)
  123. Sleep,light & cancer risk (8 replies)
  124. Cox 2 and helicobacter link. (0 replies)
  125. Cytotoxic drugs efficacy correlates with adipose tissue DHA in advanced BC (1 replies)
  126. N-Acetyl Cysteine (NAC) (2 replies)
  127. prolonged exposure to some antibiotics increased risk of her2+ brst cancer 3Xin mice (0 replies)
  128. anti TGF beta antibodies--ROLE in preventing metastases--a new targeted therapy? (0 replies)
  129. DEVELOPMENT regarding turning ER- tumors into ER+ for treatment with antiestrogens! (0 replies)
  130. Gleevec has antiangiogenic effect on prostate cancer mets to bone (0 replies)
  131. more on lapatinib--who it works on,what cardiac risks,etc (0 replies)
  132. Molecular Imaging of Breast Cancer Metastases using anti-HER2 Affibody (2 replies)
  133. cox2 inhibitors seem to impeed bone mets (2 replies)
  134. "Radioactive" Herceptin as a potential selective imaging of HER+ tumours. (0 replies)
  135. Provigil treatment improves quality of life of patients w brain cancer (0 replies)
  136. finally they are looking more critically at DCIS--receptor type influences recurrence (0 replies)
  137. New bispecific antibody targets her2 and CD3 on Tcells producing effective imm respns (2 replies)
  138. Telomerase Antagonist Effective in all major breast cancer cell lines (4 replies)
  139. Strong evidence for lignans’ breast cancer protection (58% risk reduction) (3 replies)
  140. for those of you deciding between immediate and delayed reconstruction (1 replies)
  141. for those who worry (and who doesn't?) 5 yrs of anastrozole causes osteoporosis only (1 replies)
  142. for those with micromets or individual cytokeratin+ cells in their sentinel nodes... (5 replies)
  143. first survivin inhibitor--cancer cells not only divide too much, they die too little! (1 replies)
  144. New marker/predictor(ICAM) of chemo efficacy for lung cancer(ASCO 2006) (0 replies)
  145. Newly found estrogen receptor(hER-a36):drug resistance implications? (1 replies)
  146. The gene that kills cancer: shut down oestrogen (1 replies)
  147. RB...n-3 fatty acids & gene expression (1 replies)
  148. USA TODAY article about drug costs (0 replies)
  149. unexpected patterns of lymphatic drainage (0 replies)
  150. more on tykerb and avastin (0 replies)
  151. CAD Detects Breast Cancers That Are Most Challenging to Detect (2 replies)
  152. New Drug: Tykerb targets HER-2/neu (0 replies)
  153. New treatment? (0 replies)
  154. Her2 survival beyond 5 years from 2006 ASCO (3 replies)
  155. Look what the WHO (World Health Organization) has to say about cancer (0 replies)
  156. melatonin acts as a SERM (like tamoxifen) and as an antiaromatase (1 replies)
  157. Combination "smart bomb" future of cancer therapy (0 replies)
  158. Dr Dennis Slamon gets prestigious award (0 replies)
  159. NY Times Article Providing Tykerb Overview (0 replies)
  160. Phase 1 trial:Tarveca+Celebrex for lungs (0 replies)
  161. Mechanism discovered:how inhibition of fatty acid synthetase causes apoptosisofbccell (1 replies)
  162. Question for the HER2support crew at ASCO (2 replies)
  163. Position Paper on Brain Mets presented by HER2 Support Group at ASCO (0 replies)
  164. researchers discover "finger" that triggers tumor suppression (0 replies)
  165. Provacative message on cure of her2 after 5 year DFS.... (3 replies)
  166. Al, link between appetite-controlling hormone and receptors on breast cancer cells (0 replies)
  167. Better MRI: less biopsies. New PET scan for ER+ (0 replies)
  168. NSAIDS consistently inhibit ovulation in all mammalian species investigated so far (1 replies)
  169. ***HER2+?...Exercise*** (2 replies)
  170. Inserted n6 to n3 fat gene alters n3:n6 bal from 1:15 to 1:1 (0 replies)
  171. don't forget about COX2 action (5 replies)
  172. suggests a link between hypothalamic sex steroid receptors, fatty acid metabolism, .. (2 replies)
  173. double whammy (1 replies)
  174. Goinf Offlabel (0 replies)
  175. Breast Cancer Update 2006:lots of info (3 replies)
  176. ANASTROZOLE+HERCEPTIN: possible justification (6 replies)
  177. Reasons for lapatinib resistence and how to prevent it with .......... (0 replies)
  178. cheaper herceptin equivalent "grown" in tobacco plants! (0 replies)
  179. Update On Antiangiogenesis (0 replies)
  180. Statins+insulin sensitizers (0 replies)
  181. Redistribute (if not Lose) your extra weight! (3 replies)
  182. pegylated liposomal doxorubicin (PLD) has equal efficacy but significantly less cardi (0 replies)
  183. Explaining BC to Children... (2 replies)
  184. Interesting- Reign of biotech cancer kings threatened (0 replies)
  185. adrenal androgens linked to premenopausal breast cancer risk (0 replies)
  186. Antioxidants & phytoestrogens (2 replies)
  187. recent joint analysis of the NCI adjuvant herceptin trials.... (1 replies)
  188. RB--acetylCoA carboxylase essential to breast cancer cell survival (1 replies)
  189. Research News: Vitamin E; Angiogenesis Switch (1 replies)
  190. An Expert Interview With Dr. Mark Pegram (0 replies)
  191. Immune system response (0 replies)
  192. Early peak of relapse due to micromets? (1 replies)
  193. researchers unravelling way to potentially treat herceptin resistant cancers (0 replies)
  194. curcumin mediates its effects by modulation of several important molecular targets (0 replies)
  195. Older chemo regimes: FEC reduces 10-year death risk by 48% over CMF for her2-positive (7 replies)
  196. Joe could you answer this? (3 replies)
  197. best method of minimally invasive biopsy--should posting have been on main board? (0 replies)
  198. best prices on the web!RX2006 (2 replies)
  199. Extracts From Euro Conference (0 replies)
  200. Green Tea as Cancer Treatment - Article worth reading (0 replies)
  201. Tamoxifen-Induced Anorexia Is Associated With Fatty Acid Synthase Inhibition (0 replies)
  202. Warning,careful! Need/advisability of mastectomy in her2+breast cancer (4 replies)
  203. Various leads on her2 cancer (4 replies)
  204. A Herpes Simplex virus recombinant that exhibits a single-chain antibody to HER2/... (0 replies)
  205. Surgery not verboten in metastatic breast cancer (0 replies)
  206. Can the right diet prevent breast cancer (0 replies)
  207. What to eat and avoid to prevent breast cancer (1 replies)
  208. Lovaxin B vaccine for HER2 (0 replies)
  209. One patient - Two primary and two metastatic cell lines with distinct phenotypes (0 replies)
  210. Array Comparative Genomic Hybridization Analysis of Genomic Alterations in Breast Can (0 replies)
  211. Endocrine Disrupting Compounds (0 replies)
  212. RESISTANCE TO HERCEPTIN & POTENTIAL REMEDIES (0 replies)
  213. *GINA* Copper, Magnesium, Zinc levels tied to mortality (1 replies)
  214. Scientists Spot Cancer's Shield (0 replies)
  215. Incyte Sheddase Inhibitor...attacks ALL pathways (1 replies)
  216. Affibody AB provides novel molecular imaging agents for visualizing HER2... (0 replies)
  217. new dna vaccine vs breast cancer under development in mice (0 replies)
  218. Cancer location may soon become unimportant (0 replies)
  219. White Blood Cells Cure Cancer in Mice (1 replies)
  220. Adjuvant Ovarian Suppression Versus Chemotherapy for Premenopausal, Hormone-responsiv (0 replies)
  221. "Donepezil Improves Cognition in Brain Tumor Patients" (0 replies)
  222. Striking (but anecdotal) case reports (4 replies)
  223. Protein involved in fast spreading cancers identified (1 replies)
  224. Take substances that stimulate the immune system with herceptin? (3 replies)
  225. Novel Vaccine Curbs Brain Tumor Growth (0 replies)
  226. Vitamin like compound make protect against radiation damage, leukopenia w chemo (0 replies)
  227. New partner drug with Herceptin, an HSP antagonist- Geldamycin (0 replies)
  228. Intrathecal Herceptin May Halt Cancer Progression of Central Nervous System (1 replies)
  229. when treated with trastuzumab, HER2+ metsmets... (0 replies)
  230. pTEN and herceptin response.... (2 replies)
  231. Higher cardiac events from letrozole... (0 replies)
  232. Oral contraception and increased bc risk from NEJM's April issue (0 replies)
  233. Bionovo drug shows potential in aggressive breast cancer (0 replies)
  234. cross-talk between Er alpha and EGFR regulates tamoxifen resistant bc growth(bidrctnl (0 replies)
  235. Hrt (0 replies)
  236. Foods may affect the brain as well as the body (0 replies)
  237. Getting antiher2 therapies into cells while avoiding other her2+ cells (0 replies)
  238. Get Involved and Fill Out a Paid Questionnaire on Working After Breast Cancer (1 replies)
  239. Study links cancer, inflammatory disease (1 replies)
  240. A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes... (0 replies)
  241. Ginkgo Biloba Extract May Have Anti-Cancer Properties (0 replies)
  242. Cancers drug resistance (1 replies)
  243. vesiculated vitamin E derivative plus pulsed dendritic cell vaccine!!! (0 replies)
  244. Herceptin in Spotlight (0 replies)
  245. gene therapy treatment for her2+....with hMtd (0 replies)
  246. Today's presentation in 5th European Breast Cancer Conference 2006 (1 replies)
  247. anti-angiogenesis converting cancer to managed disease (1 replies)
  248. UPenn progress on blood test to detect v. early her2 breast cancer/recurrence (1 replies)
  249. Genetic step leading to her2 breast cancer development found (9 replies)
  250. trial of new multitargeted tyrosine kinase inhibitor (0 replies)